Menu
Search
Home > Courses > Therapeutic Strategies Aimed at Achieving Antiretroviral Drug-Free HIV Remission

Therapeutic Strategies Aimed at Achieving Antiretroviral Drug-Free HIV Remission

Therapeutic Strategies Aimed at Achieving Antiretroviral Drug-Free HIV Remission
Play
Sorry, this learning module is not available for mobile devices.
Original Release Date: 12/11/2018
Termination Date: 12/10/2021
Review Date: 4/8/2019
Presenter
  • Tae-Wook Chun, PhD
    Associate Scientist
    National Institute of Allergy and Infectious Diseases
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Understand the impact of analytical treatment interruption on immunologic and virologic parameters in HIV-infected individuals.
  2. Know the outcome of recent therapeutic clinical trials aimed at achieving sustained virologic remission in HIV-infected individuals in the absence of antiretroviral therapy.
  3. Be aware of an on-going clinical trial being conducted at the National Institute of Allergy and Infectious Diseases involving two HIV-specific broadly neutralizing antibodies.
Presenter Bio
Tae-Wook Chun, PhD
Tae-Wook Chun received his PhD in Biochemistry, Cellular, and Molecular Biology from Johns Hopkins University School of Medicine. In 1997, he identified and characterized latently infected, resting CD4+ T cells in HIV-infected individuals. He then pursued postdoctoral work at the NIH, where he demonstrated that latent HIV reservoir persists in virtually all infected individuals receiving antiretroviral therapy despite effective suppression of plasma viremia, and that early initiation of antiretroviral therapy leads to a decay of the latent viral reservoir. He is currently an Associate Scientist at the NIH and continues to study the role of viral reservoirs in the pathogenesis of HIV disease and is working towards developing therapeutic strategies aimed at achieving sustained virologic remission in infected individuals without antiretroviral therapy.
Continuing Education Credit

This CME activity was approved for AMA PRA Category 1 Credit on December 11, 2018 and will terminate December 10, 2021.

The target audience is all physicians, NPs and PAs involved or interested in HIV education.

This online video and post-activity evaluation are one hour in length.

  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz.
  • You must achieve at least 70% correct to receive your CME certificate.
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.

 Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Medical Society of the State of New York (MSSNY) and the Physicians’ Research Network (PRN). MSSNY is accredited by the ACCME to provide continuing medical education for physicians.

The Medical Society of the State of New York designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim only the credit commensurate with extent of their participation in the activity.

Disclosure Statement 

Policies and standards of MSSNY require that speakers and planners for CME activities disclose any relevant financial relationships they may have with commercial interests whose products, devices or services may be discussed in the content of a CME activity.  

  • Dr. James Braun (Planner/Course Director) had no relevant financial relationships to disclose.
  • Tae-Wook Chun, PhD (Presenter) had no relevant financial relationships to disclose. Dr. Chun submitted his slides in advance for adequate peer review, and will support his presentation and clinical recommendations with the best available evidence from medical lliterature.

Financial Support

This meeting of the Physicians’ Research Network (PRN) and enduring material were funded in part by educational grants from: Gilead Sciences, Janssen Therapeutics (a division of Janssen Products, LP), Merck & Co., and ViiV Healthcare.

Details: 

  • This online video and post-activity evaluation are one hour in length. 
  • After you complete the video portion of this educational activity there will be a post-activity evaluation and quiz. 
  • You must achieve at least 70% correct to receive your CME certificate. 
  • If successful, you will be provided instructions to print your CME certificate at the completion of this activity.
PRN Learning Modules